Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The CADEUS study: methods and logistics.

F Depont1, A Fourrier, Y Merlière

  • 1Département de Pharmacologie, Université Victor Segalen, Bordeaux, France.

Pharmacoepidemiology and Drug Safety
|November 24, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adherence to Direct Oral Anticoagulants in Patients With Non-Valvular Atrial Fibrillation: A Cross-National Comparison in Six European Countries (2008-2015).

Frontiers in pharmacology·2021
Same author

[Use and misuse of benzodiazepines out of France].

Presse medicale (Paris, France : 1983)·2018
Same author

[Pulmonary nocardiosis with cerebral abscesses mimicking metastatic lung cancer: Three cases and a review of literature].

Revue des maladies respiratoires·2017
Same author

The 3.5-Year Mortality Impact Of Drugs In Secondary Prevention Of Myocardial Infarction In Real-Life (Interim Analysis Of The Eole Cohort).

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

Misuse, Abuse, and Diversion of instanyl® (Fentanyl Nasal Spray) in France.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

[Exception drugs status: specific characteristics and the role in the proper use of drugs].

Revue d'epidemiologie et de sante publique·2013
Same journal

Trends in Pharmacist-Prescribed Dispensing Records of HIV Pre-Exposure (2020-2025) and Post-Exposure Prophylaxis (2020-2024) in Brazil: A Time Series Analysis.

Pharmacoepidemiology and drug safety·2026
Same journal

French Consumption of Methylphenidate in Primary Care From 2016 to 2023, Impact of Prescribing Policy Changes-A Time-Series Analysis.

Pharmacoepidemiology and drug safety·2026
Same journal

Uptake and Use of Biologic Therapies in Paediatric Immune-Mediated Inflammatory Diseases: An Australian Population-Based Study.

Pharmacoepidemiology and drug safety·2026
Same journal

Comparative Effectiveness of Oral Fluoropyrimidines Versus FOLFOX as Adjuvant Therapy for Stage III Colon Cancer: A Retrospective Cohort Study Using Overlap-Weighted Restricted Mean Survival Time Analysis.

Pharmacoepidemiology and drug safety·2026
Same journal

Association Between EGFR-TKI-Associated Skin Rash and Recorded Mortality in Non-Small Cell Lung Cancer: A Real-World Analysis Accounting for Immortal Time Bias.

Pharmacoepidemiology and drug safety·2026
Same journal

Nationwide Trends in Opioid Consumption in Costa Rica, 2017-2024: Implications for Regulatory Policy and Public Health.

Pharmacoepidemiology and drug safety·2026
See all related articles

The CADEUS study described users of cyclo-oxygenase (COX)-2 inhibitors and non-steroidal anti-inflammatory drugs (tNSAIDs) in France. Patient and prescriber response rates were assessed, with factors like age influencing patient participation.

Area of Science:

  • Pharmacovigilance and Drug Utilization Studies
  • Epidemiology of Musculoskeletal and Inflammatory Diseases
  • Health Services Research

Background:

  • Cyclo-oxygenase (COX)-2 inhibitors and traditional non-selective non-steroidal anti-inflammatory drugs (tNSAIDs) are widely used for pain and inflammation.
  • Understanding user profiles and prescribing patterns is crucial for optimizing drug safety and efficacy.
  • The CADEUS study was initiated at the request of French Health authorities to address these needs.

Purpose of the Study:

  • To describe the characteristics of patients using COX-2 inhibitors and tNSAIDs.
  • To evaluate the methodology, logistics, and performance of a large-scale cohort study design.
  • To gather data on drug indications, medical history, and healthcare resource utilization.

Main Methods:

Related Experiment Videos

  • A cohort study design involving 40,000 patients randomly sampled from the French National Healthcare Insurance database.
  • Inclusion criteria: patients receiving celecoxib, rofecoxib, or tNSAIDs between September 2003 and August 2004.
  • Data collection via patient and prescriber questionnaires, supplemented by healthcare resource data extraction from the claims database.

Main Results:

  • A total of 222,879 patients and prescribers were contacted, with response rates of 20.8% for patients and 32.6% for prescribers.
  • Median response delays were 16 days for patients and 17 days for physicians.
  • Patient response was associated with age, cohort, prescriber type, and period of inclusion.

Conclusions:

  • The CADEUS study represents a novel approach in France by integrating claims database information with direct patient and prescriber feedback.
  • The study provides valuable insights into the utilization patterns of COX-2 inhibitors and tNSAIDs.
  • The findings can inform public health strategies and improve the safe use of these medications.